Satyabrata Sinha

Summary

Publications

  1. ncbi Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma
    Satyabrata Sinha
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India
    Mol Cancer 7:84. 2008
  2. ncbi Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications
    Satyabrata Sinha
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India
    Mol Oncol 5:454-64. 2011
  3. ncbi Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance
    Satyabrata Sinha
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India
    Cancer Sci 99:1984-91. 2008
  4. ncbi Association of APC and MCC polymorphisms with increased breast cancer risk in an Indian population
    Nupur Mukherjee
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India
    Int J Biol Markers 26:43-9. 2011
  5. ncbi Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma
    Satyabrata Sinha
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S P Mukherjee Road, Kolkata, 700026, India
    Ann Surg Oncol 15:1070-80. 2008

Collaborators

  • Nupur Mukherjee
  • Susanta Roychoudhury
  • Nilanjana Bhattacharya
  • Neyaz Alam
  • Runu Chakravarti
  • Chinmay Kumar Panda

Detail Information

Publications5

  1. ncbi Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma
    Satyabrata Sinha
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India
    Mol Cancer 7:84. 2008
    ..4 Mb region of the afore-said locus in two age groups of BC, as well as the interrelation and prognostic significance of alterations of these genes...
  2. ncbi Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications
    Satyabrata Sinha
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India
    Mol Oncol 5:454-64. 2011
    ..Thus, our study suggests that LOH11CR2A, PIG8 and CHEK1 are candidate tumor suppressor genes associated with breast carcinoma and have significant clinical as well as prognostic importance...
  3. ncbi Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance
    Satyabrata Sinha
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India
    Cancer Sci 99:1984-91. 2008
    ..Thus, the present study suggests hMLH1 and RBSP3/HYA22 to be candidate TSG associated with development of both early and late-onset BC undergoing frequent genetic and epigenetic alteration and having significant prognostic implications...
  4. ncbi Association of APC and MCC polymorphisms with increased breast cancer risk in an Indian population
    Nupur Mukherjee
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India
    Int J Biol Markers 26:43-9. 2011
    ..045) of the breast cancer patients in our study, in particular patients with early-onset BC...
  5. ncbi Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma
    Satyabrata Sinha
    Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S P Mukherjee Road, Kolkata, 700026, India
    Ann Surg Oncol 15:1070-80. 2008
    ..This study attempts to understand the association of candidate tumour suppressor genes SH3GL2, CDKN2A (p16-p14) and CDKN2B (p15) in development of early-onset (group A) and late-onset (group B) breast carcinoma (BC)...